HomeHLEGLAS › Filing
🔔 Get instant alerts when HLEGLAS files quarterly results on BSE Start free trial →

HLE Glascoat Limited has informed the Exchange regarding a press release dated August 10, 2026, titled "Press Release Q1 FY 2026-27".

Filed: 10 Aug 2026, 23:59 IST Exchange: BSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Revenue 300.8 Cr +5.9% y-y; EBITDA 22.6 Cr (margin 7.5%); PAT 2.1 Cr (margin 0.7%) - Orderbook healthy at 713.8 Cr as of July 31, 2026, supporting future growth - Demand showed early improvement in latter half of quarter after geopolitical and economic volatility - Filtration segment revenue down 15.9% y-y; Glass Lined Products up 49.0% y-y; Heat Transfer down 72.6% y-y - Management confident of sustained growth driven by process automation and capacity expansion in pharma and specialty chemicals
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 HLEGLAS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add HLEGLAS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on HLE Glascoat Limited

Important. The summary above is generated automatically from HLE Glascoat Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.